A 94-year-old man with NYHA class III heart failure who underwent transcatheter aortic valve replacement (TAVR) with a 34 mm Evolut R self-expandable heart valve (Medtronic, Inc) for severe aortic stenosis (AS) 3 months prior presentation, presented with dyspnea and confusion. An unenhanced computed tomography of the chest showed the aortic prosthetic valve in place along a prominent aneurysmal dilation of the ascending thoracic aorta and internal displacement of mural calcifications toward the aortic lumen, suggestive of a Stanford type A aortic dissection (Figure 1, panel A, B) . A transthoracic echocardiogram showed a severely dilated aorta with a complex intimal flap 
Abstract
Aortic dissection is a rare but life-threatening complication of transcatheter aortic valve replacement, clinicians should be aware of this complication and should consider timely diagnostic evaluations, as well as, establish a prompt treatment plan based on a multidisciplinary team approach.
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cardiothoracic surgery, cardiovascular disorders, critical care medicine, emergency medicine consistent with an aortic dissection (Figure 1, panel C, D) . Due to his advanced age and high surgical risk, his family decided to forgo any surgical intervention and transition care toward comfort care.
Transcatheter aortic valve replacement has replaced surgical aortic valve replacement as the treatment of choice for symptomatic severe AS in patients at high surgical risk. Aortic dissection (AD) is a life-threatening complication of TAVR, reported in 0.6%-1.9% of cases. 1 Conventionally, the treatment of AD is emergent open surgical repair; however, its management in TAVR patients is challenging because they are already at high operative risk. More recently, less invasive procedures have gained popularity. Yet, the lack of evidence-based data and guidelines on its management makes it a treatment dilemma.
